lycobetaine analogs (Oncotest)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug Namelycobetaine analogs (Oncotest)
Drug Alias Nametopoisomerase inhibitors (Oncotest)E-761E-758E-759
ClassificationSmall molecules
Mechanisms of ActionDNA topoisomerase inhibitors
TargetsDNA topoisomerase
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesOncotest GmbH
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesOncotest GmbH
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A